OSTEOPOROSE: UM ARTIGO DE ATUALIZAÇÃO - Ucg

74. Fuerst T, Gluer CC, Genant HK. Quantitative ultrasound. Eur J Radiol 1995; 20: 188-92
apud Szejnfeld VL. 2004.
36
75. Heaney RP, Avioli LV, Chesnut CH III, Lappe I, Recker RR, Brandenburger GH.
Osteoporotic bone fragility: detection by ultrasound transmission velocity. JAMA 1989; 261:
2986-90 apud Szejnfeld VL. 2004.
76. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy.
JAMA 2001; 285: 785-95 apud Szejnfeld VL. 2004.
77. Lindsay R. The menopause sex steroids and osteoporosis. Clin Obstet Gynecol 1987; 30:
847-59 apud Costa-Paiva L, Horovitz AP, Santos AO, Fonsechi-Carvasan GA, Pinto-Neto
AM. 2003.
78. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of
nonvertebral fractures: a meta-analysis of randomized trials. JAMA 2001; 285: 2891- 97 apud
Costa-Paiva L, Horovitz AP, Santos AO, Fonsechi-Carvasan GA, Pinto-Neto AM. 2003.
79.Yasui T, Uemura H, Takikawa M, Irahara M. Hormone replacement therapy in
postmenopausal women. J Med Invest 2003; 50(3-4): 136-45.
80. Fedelesova V, Chylova K, Dzurik. Treatment of postmenopausal osteoporosis with
raloxifene. Bratisl Lek Listy 2000; 101(9): 527-8.
81. Russo LAT. Osteoporose pós-menopausa: opções terapêuticas. Arq Bras Endocrinol
Metab 2001; 45(4): 401-6
82. Delmas PD. Treatment of postmenopausal osteoporosis-state of the art. Osteoporosis Int
2001; 12(suppl 1): 1-48.
83. Kushida K, Shiraki M, Nakamura T, Kishimoto H, Morii H, Yamam K, et al. Alendronate
reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-
year follow-up study. J Bone Miner Metab 2004; 22(5): 462-8.